COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
Study Information
Study Attribute Value
CEBS Accession Number: 002-02094-0002-0000-9
Chemical Name: Disperse blue 7
CASRN: 3179-90-6
NTP Study Type: Genetic Toxicology - Mammalian Cell Cytogenetics
NTP Study ID: 264454_CA
Study Result: Positive

Study Result: Positive
Activation Trial Trial Call
No Activation  Positive 
Induced Rat Liver S9  1_S9  Positive 
No Activation  Positive 

Trial #:1   Activation: No Activation    Date: 12/08/1988    Harvest Time: 12 hour(s)   Trial Call: Positive   
  Dose
µg/mL
Total
Cells Examined
Total Aberrations Complex Aberrations Simple Aberrations Other Abs
No. of
Abs
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
Vehicle Control: Negative (Not Specified)
0         
200 0 0.000 0.0 0 0.000 0.0 0 0.000 0.0 0 0.000 0.0
Test Chemical: Disperse blue 7
25         
50 64 1.280 72.0 35 0.700 46.0 29 0.580 44.0 0 0.000 0.0
50         
50 54 1.080 62.0 30 0.600 48.0 24 0.480 34.0 0 0.000 0.0
100         
50 78 1.560 76.0 43 0.860 60.0 35 0.700 50.0 0 0.000 0.0
Positive Control: Mitomycin-C
 0.125     
200 55 0.275 23.5 20 0.100 9.5 35 0.175 15.5 0 0.000 0.0
Mitomycin-C
 0.25      
50 25 0.500 42.0 10 0.200 20.0 14 0.280 24.0 1 0.020 1.0
Trend: 12.651 10.898 9.360  
Probability: 0.000 0.000 0.000  


Trial #:1_S9   Activation: Induced Rat Liver S9    Date: 11/10/1988    Harvest Time: 13 hour(s)   Trial Call: Positive   
  Dose
µg/mL
Total
Cells Examined
Total Aberrations Complex Aberrations Simple Aberrations Other Abs
No. of
Abs
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
Vehicle Control: Negative (Not Specified)
0         
200 1 0.005 0.5 1 0.005 0.5 0 0.000 0.0 0 0.000 0.0
Test Chemical: Disperse blue 7
1000         
100 41 0.410 32.0 25 0.250 20.0 16 0.160 15.0 0 0.000 0.0
1600         
100 80 0.800 52.0 35 0.350 31.0 34 0.340 28.0 11 0.110 2.0
3000         
100 61 0.610 43.0 33 0.330 29.0 26 0.260 18.0 2 0.020 2.0
Positive Control: Cyclophosphamide
5         
200 29 0.145 8.0 4 0.020 2.0 14 0.070 6.0 11 0.055 2.0
Cyclophosphamide
7.5       
50 17 0.340 30.0 2 0.040 4.0 14 0.280 26.0 1 0.020 1.0
Trend: 9.606 7.368 5.896  
Probability: 0.000 0.000 0.000  


Trial #:2   Activation: No Activation    Date: 11/10/1988    Harvest Time: 12 hour(s)   Trial Call: Positive   
  Dose
µg/mL
Total
Cells Examined
Total Aberrations Complex Aberrations Simple Aberrations Other Abs
No. of
Abs
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
Vehicle Control: Negative (Not Specified)
0         
200 1 0.005 0.5 1 0.005 0.5 0 0.000 0.0 0 0.000 0.0
Test Chemical: Disperse blue 7
100         
50 65 1.300 78.0 29 0.580 44.0 36 0.720 50.0 0 0.000 0.0
160         
50 55 1.100 68.0 30 0.600 44.0 24 0.480 42.0 1 0.020 1.0
300         
50 76 1.520 86.0 41 0.820 46.0 35 0.700 56.0 0 0.000 0.0
500         
16 25 1.563 75.0 12 0.750 43.8 13 0.813 62.5 0 0.000 0.0
1000         
15 18 1.200 73.3 9 0.600 46.7 9 0.600 46.7 0 0.000 0.0
Positive Control: Mitomycin-C
 0.125     
200 57 0.285 21.5 20 0.100 10.0 27 0.135 12.0 10 0.050 1.0
Mitomycin-C
 0.25      
50 26 0.520 38.0 12 0.240 22.0 14 0.280 26.0 0 0.000 0.0
Trend: 12.754 8.703 9.831  
Probability: 0.000 0.000 0.000